Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-017583
Filing Date
2017-03-17
Accepted
2017-03-17 16:01:45
Documents
6
Effectiveness Date
2017-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 a17-8456_1s8.htm S-8 113402
2 EX-5.1 a17-8456_1ex5d1.htm EX-5.1 13446
3 EX-23.2 a17-8456_1ex23d2.htm EX-23.2 3742
4 GRAPHIC g84561kei001.jpg GRAPHIC 1252
5 GRAPHIC g84561kei002.jpg GRAPHIC 1401
6 GRAPHIC g84561kei003.gif GRAPHIC 7831
  Complete submission text file 0001104659-17-017583.txt   146515
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216793 | Film No.: 17697888
SIC: 2834 Pharmaceutical Preparations